Synergy Pharma (SGYP) Tops Q1 EPS by 1c, Sales Miss; Guides Lower

Synergy Pharma (NASDAQ: SGYP) reported Q1 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.6 million versus the consensus estimate of $11.5 million.

GUIDANCE:

Synergy Pharma sees FY2018 revenue of $165-175 million, versus $175-$185 million prior and the consensus of $190.8 million.

For earnings history and earnings-related data on Synergy Pharma (SGYP) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
• Innovaro (INV) Misses Q2 EPS by 9c